Introduction: Gastric cancer is a leading cause of cancer related mortality in Singapore and open surgical resection with en-bloc lymphadenectomy is currently the standard of care. While the benefits of laparoscopic surgery for other cancers such as colorectal cancer have been widely accepted. It has seen slower acceptance for gastric cancer due to the steep learning curve, concerns regarding long-term oncological outcome and adequacy of harvested lymph nodes. Our study aims to compare our institution's short term outcomes of laparoscopic gastrectomies (LG) for cancer to open gastrectomy (OG).
INTRODUCTION
Gastric cancer is the seventh most common cancer among males in Singapore, and the third leading cause of cancer death worldwide. (1) Despite advances in chemotherapy, radiotherapy and targeted therapy, surgery remains the only method to achieve cure for gastric cancer. (2) Open surgical resection with en-bloc lymphadenectomy is currently the standard of care for gastric cancer. The first laparoscopic-assisted distal gastrectomy with modified D1 lymph node dissection was performed in 1994 by Kitano(3) for the treatment of early gastric cancer. While the use of laparoscopic surgery for early gastric cancer is largely accepted, the use of laparoscopic gastrectomy for advanced gastric cancer is still controversial.(4) Laparoscopic gastrectomy has short term advantage in the early recovery of patients such as decreased intra-operative blood loss and post-operative early morbidity. (5) While laparoscopic surgery for surgical procedures like appendectomies and cholecystectomies is starting to replace open surgeries, laparoscopic gastrectomy has seen slower acceptance for gastric cancer. Cited limitations include its steep surgical learning curve, initial concerns regarding long-term oncological outcome and adequacy of harvested lymph nodes.
Laparoscopic
gastrectomies have been performed in our institution since 2008. The purpose of this study is to evaluate the shortterm outcomes of laparoscopic gastrectomies for gastric cancer compared to open gastrectomy in our institution.
METHODS
This retrospective review was performed with the approval of the Institution Review Board (Reference number; 2016/01052). The study cohort included patients who underwent either open or laparoscopic gastrectomies for histologically confirmed gastric adenocarcinoma from January 2008 to December 2015. Patients who had Stage 4 gastric cancer, underwent gastrectomy for palliation, or underwent gastrectomy for recurrent gastric cancer were excluded from this study. The decision to undertake either an open or laparoscopic approach was made after discussion between the attending surgeon and the patient. The surgery was performed by one of four upper gastrointestinal consultant surgeons in our institution. All partial or total gastrectomies were performed with the intention of a D2 lymphadenectomy as per Japanese gastric cancer treatment guidelines. Morbidity was graded according to the Clavien Dindo classification and included for analysis if they were Grade 2 and above.
Patient Characteristics and Clinical Data
Patient characteristics were obtained from a review of the medical records. Demographic data included age at diagnosis, sex, race, American Society of Anesthesiologists (ASA) physical status classification score and body mass index. Clinicopathological characteristics included the location of the tumours, histological grade, TNM stage and operation method. Stage at diagnosis was determined according to the 7th Edition of TNM staging system of gastric cancer, in accordance with the American Joint Committee on Cancer (AJCC) classification system. Operative outcomes such as 30-day morbidity and mortality, as well as recurrence and survival were included.
Follow-Up Schedule
All patients were followed up for five years, three monthly for the first two years, and six monthly for the subsequent three years. Annual Computer Tomographic (CT) scans of the abdomen and pelvis, and gastroscopy were performed to assess for local and distant recurrence. Those losses to follow-up and deaths were treated as censored.
Statistical Analysis
Patient demographics, tumour characteristics, operative details and post-operative outcomes were analyzed using SPSS version 21 for windows (SPSS Inc., Chicago, Il, USA). Data was presented as mean and standard deviations for variables that following normal distribution and were analyzed by t test. For variables following non-normal distribution, results were expressed as median and range, and were compared with nonparametric tests. Semiquantitative results were analyzed by Mann-Whitney U-test, while categorical results were analyzed by chi-square tests or Fisher exact test as appropriate. The overall survival was assessed from the date of gastrectomy until the last follow up or death or any cause. The disease-free survival was calculated from the date of gastrectomy until the date of cancer recurrence or death from any cause. Recurrence and disease free-survival curves were generated by Kaplan-Meier method, and analyzed using the log rank test. Statistical significance was taken at the level of P value less than 0.05. The analysis was performed on an intention-to-treat basis.
RESULTS

Patient Demographics
There were a total of 164 patients who underwent gastrectomies for gastric cancer from 2008 to 2015 in our institution. Mean age was 67 years old, 63% (n=104) of them were of male gender, and majority were Chinese (n=153, 93%). Average body mass index (BMI) was 22.9 kg/m 2 , and majority had an American Society of Anaesthesiologists (ASA) score of either 2 (n=90, 55%) or 3 (n=63, 38%). Patients who underwent laparoscopic resection had a significantly higher BMI as compared to those who went for open surgery (23.4 vs 21.8 kg/m 2 , p=0.012). Patient demographic details are further elaborated in Table 1 . Fig. 1-3 ). There was no statistically significant difference between 30-day morbidity and 30-mortality between both groups, as further demonstrated in Tables 2 and 3 .
Disease Characteristics
Fig1. Kaplan Meier curve for Survival (1a) and Time to Recurrence (1b) for Stage 1 gastric cancer
Kaplan Meier survival curves were performed for survival and time to recurrence by location of tumour. There was no significant difference in survival and time to recurrence between the 2 surgical techniques for upper and diffuse tumours, however there was significantly better survival and time to recurrence when laparoscopic surgery was performed for mid and lower tumours ( Fig. 4 (12) reported survival rates of 68.1% and 63.7% for laparoscopic and open gastrectomy respectively. Multivariate analysis did not find any significant difference for death rate and recurrence after adjustment for stage of tumour. Comparisons of same-stage patient survival curves in laparoscopic and open gastrectomy revealed no differences in the 5year survival rates, a finding that is consistent with larger studies. (9, 12) This demonstrates that the survival rates of patients with gastric cancer are affected by the stage of the tumour, rather than the surgical method. Pak et al (13) analysed 714 patients who underwent laparoscopic gastrectomy for gastric cancer, and found that the 5-year overall survival rates were 96.4% for stage I, 83.1% for stage II, and 50.2% for stage III gastric cancers. This indicates that laparoscopic gastrectomy for gastric cancer had acceptable oncological outcomes. A metaanalysis by Chen et al (14) showed that the longterm survival and recurrence rates of laparoscopic gastric cancer surgery are comparable to those of open surgery for both early and advanced gastric cancer.
Neoadjuvant chemotherapy is not widely carried out in our institution; only 5.5% of the patients in our series underwent neoadjuvant chemotherapy. The last edition of the Japanese Gastric Cancer Association guidelines (4) still consider neoadjuvant chemotherapy investigational while awaiting the results of dedicated ongoing trials. In our analysis, there was significantly better survival and time to recurrence when laparoscopic surgery was performed for mid and distal tumours, but not for upper and diffuse tumours. Location of tumour may affect the prognosis and type of surgery performed. Tumours in the proximal third of the stomach are likely to be of larger size, have more extensive wall penetration, nodal metastasis and more advanced stage, with an overall worse survival relative to tumours in the antrum (15) . Total gastrectomy is performed for proximal tumours and linitisplastica, while subtotal gastrectomy may be performed for distal gastric tumours.
The learning curve of laparoscopic gastrectomy is a steep one. Kim et al showed that a minimum of 50 cases of laparoscopic gastrectomies for early gastric cancer is required to achieve competence and significantly improved operative time. (16) The greater proportion of patients with advanced gastric cancer in the open surgery group in our series is due to careful patient selection for laparoscopic surgery.
Our study has some limitations. It is a retrospective non-randomized study conducted in a single-centre. There are also significant differences between the 2 patient groups with regards to location and stage of the tumour, which affects overall survival and disease-free recurrence. More patients in the open group had previous laparotomies, and this could also have resulted in bias. In our study, the open group had significantly lower operative time with a trend towards higher blood loss. We believe that the higher intra-operative blood loss in the open group could have been contributed by a greater proportion of higher stage tumours and a higher rate of previous laparotomies. We have attempted to address this through multi-variate analysis and Kaplan Meier analysis stratified by stage of disease and location of tumour. While this study has shown that laparoscopic gastrectomy is comparable to open gastrectomy with regards to technical safety and oncological outcomes, a clear clinical advantage for laparoscopic over open is not demonstrated. Further studies evaluating quality of life and post-operative pain between laparoscopic and open surgery should be conducted.
CONCLUSION
In our study, there was no difference in shortterm outcomes between laparoscopic and open surgery. Survival and time to recurrence is affected by tumour, rather than the surgical method (14) . Laparoscopic gastrectomy with D2 lymph node dissection can be considered a safe and feasible procedure for gastric cancer. Further trials can be carried out to assess potential benefits of laparoscopic gastrectomy over open gastrectomy.
